TY - JOUR T1 - Correction to “Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9” JF - Molecular Pharmacology JO - Mol Pharmacol SP - 1190 LP - 1190 DO - 10.1124/mol.80.6.1190 VL - 80 IS - 6 A2 - , Y1 - 2011/12/01 UR - http://molpharm.aspetjournals.org/content/80/6/1190.abstract N2 - ER -